It's more than a result.
It's a person.

We're Driven To Know.


Innovative solutions that empower researchers, from ALS to fragile X syndrome.

Learn more about our Genetics portfolio

Solving complex molecular challenges, from leukemia to solid tumors.

Learn more about our Oncology portfolio
Custom & Companion Diagnostics

One partner from clinical concept to product commercialization.

Learn more about partnering with us.

Asuragen Announces the Launch of AmplideX PCR/CE SMN1 Kit

The AmplideX PCR/CE SMN1 kit allows laboratories to quickly and easily determine SMN1 exon 7 copy number.

Learn more

Asuragen Expands Genetic Portfolio with Launch of AmplideX PCR/CE DMPK Kit

The launch of the AmplideX PCR/CE DMPK Kit represents an extension of Asuragen’s portfolio of easy-to-use testing kits for complex and challenging genetic targets.

Read more

Asuragen Obtains CE Mark of QuantideX® qPCR BCR-ABL Kits on Roche Diagnostics cobas z 480 Analyzer

Asuragen expands CE mark of the QuantideX® qPCR BCR-ABL IS Kit and QuantideX® qPCR BCR-ABL minor Kit to include clinical use on the Roche Diagnostics cobas z 480 Analyzer.

Read More

The Latest from Asuragen

New Frontiers for AmplideX Technology: Portfolio Expansion to New High Complexity Targets
Back To